Marijuana-based anti-seizure drug may hit U.S. market in 2018 after strong study results

A new class of epilepsy medications based on an ingredient derived from marijuana could be available as soon as in the second half of 2018 in the United States pending Food and Drug Administration approval. Officials from GW Pharmaceuticals, the company that developed the drug, on Wednesday announced promising results from a study on 171 patients randomized into treatment and placebo […]Related:Paramedics said her 6-year-old had common flu symptoms and left, she claims. Now her daughter is dead.NIH adopts new rules on human research, worrying behavioral scientistsThis flu season keeps getting deadlier, and a shutdown will make things worse
Source: Washington Post: To Your Health - Category: Consumer Health News Source Type: news